吸收问题:更仔细地看看药物批准的口服生物可用性规则
Artur Caminero Gomes Soares1, Gustavo Henrique Marques Sousa1, Raisa Ludmila Calil1
1School of Pharmaceutical Sciences, University of São Paulo, Department of Pharmacy, Laboratório de Integração entre Técnicas Experimentais e Computacionais (LITEC), Av. Prof. Lineu Prestes, 580, São Paulo, SP, Brazil.
Molecular informatics
|August 7, 2023
概括
盲目应用利宾斯基五项规则 (Ro5) 和维伯规则可以排除可行的候选药物. 药物化学家应该谨慎地使用这些药物相似度启发式,在必要时对口服生物可用性进行探索.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 药理动力学 药理动力学
背景情况:
- 利宾斯基五项规则 (Ro5) 和维伯规则是早期药物开发中广泛使用的启发式方法,用于预测口服生物可用性.
- 这些规则评估候选药物的物理化学特性,以估计它们的成功概率.
研究的目的:
- 评估自1997年以来Ro5和维伯规则对FDA批准的口服药物的影响.
- 评估这些药物相似性规则随着时间的推移的遵守和一致性.
- 为药物化学家提供有关在药物发现中应用这些规则的见解.
主要方法:
- 从1997年起,对FDA批准的口服药物的物理化学特性进行分析.
- 对遵守Ro5和维伯规则标准的定量评估.
- 评估随着时间的推移,规则遵守和特定参数一致性的趋势.
主要成果:
- 大约66%的口服药物符合Ro5,85%符合维伯规则.
- 分子重量和LogP是最少遵循的规则,显示一致性较低.
- 结合规则和可旋转结合规则得到了高度遵守和一致.
- 拓极地表面积和键数是不可互换的.
结论:
- 过度依赖Ro5和维伯规则可能导致潜在有效药物化合物的排除.
- 这些规则应该作为指南,而不是严格的限制,鼓励对口服生物可用性的各种化学空间的探索.
- 药物化学家必须平衡对启发式的坚持与创新和探索新化学实体的需要.
相关概念视频
Factors Influencing Drug Absorption: Drug Dissolution
570
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
570
Factors Influencing Bioavailability: First-Pass Elimination
6.5K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.5K
Bioavailability: Overview
2.9K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.9K
Factors Influencing Drug Absorption: Physicochemical Parameters
323
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
323
Drug Absorption: Overview
660
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
660
Factors Influencing Drug Absorption: Disease States and Pharmacology
565
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
565


